ALMS

NASDAQ · Pharmaceuticals

Alumis Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$24.51

-0.09 (-0.37%)

As of Jun 23, 9:58 PM ET ·

Day Range $23.47 — $24.96

52W Range $2.76 — $30.60

Performance

1D —

1W —

1M —

3M —

6M +123.43%

1Y +714.29%

YTD +173.70%

Open$24.00

Previous Close$24.60

Day High$24.96

Day Low$23.47

52W High$30.60

52W Low$2.76

Volume—

Avg Volume1.55M

Market Cap2.98B

P/E Ratio—

EPS$-1.93

SectorPharmaceuticals

Technical Indicators

Full analysis →

SMA 50 $19.51 Above

SMA 200 $8.26 Above

RSI (14) 60.5 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

17 analysts

15 Buy 2 Hold 0 Sell

Price Target +0.0% upside

Current
$24.51

Target
$24.51

$15.34 $24.51 avg $36.47

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	36.05M	878.33M	917.39M
Net Income	-364,831,043	120.27M	166.79M
Profit Margin	-1,011.8%	13.7%	18.2%
EBITDA	-393,440,243	272.46M	241.94M
Free Cash Flow	—	126.96M	147.40M
Rev Growth	—	+6.0%	+16.1%
Debt/Equity	—	0.25	0.30

Pharmaceuticals Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
LLY	Eli Lilly and Co.	$1,107.08	+0.45%	40.9	1.03T
JNJ	Johnson & Johnson	$239.08	+3.37%	26.1	549.78B
MRK	Merck & Co. Inc.	$119.60	+3.57%	31.5	281.24B
PFE	Pfizer Inc.	$24.72	-1.44%	19.2	143.68B
BMY	Bristol-Myers Squibb Co	$55.53	+1.52%	18.5	110.27B
ZTS	Zoetis Inc	$76.84	+1.25%	12.5	33.00B